Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Hypoxia-inducible factor-1 (HIF-1) is a transcriptional complex that controls cellular and systemic homeostatic responses to oxygen availability. HIF-1 alpha is the oxygen-regulated subunit of HIF-1, an alpha beta heterodimeric complex. HIF-1 alpha is stable in hypoxia, but in the presence of oxygen it is targeted for proteasomal degradation by the ubiquitination complex pVHL, the protein of the von Hippel Lindau (VHL) tumour suppressor gene and a component of an E3 ubiquitin ligase complex. Capture of HIF-1 alpha by pVHL is regulated by hydroxylation of specific prolyl residues in two functionally independent regions of HIF-1 alpha. The crystal structure of a hydroxylated HIF-1 alpha peptide bound to VCB (pVHL, elongins C and B) and solution binding assays reveal a single, conserved hydroxyproline-binding pocket in pVHL. Optimized hydrogen bonding to the buried hydroxyprolyl group confers precise discrimination between hydroxylated and unmodified prolyl residues. This mechanism provides a new focus for development of therapeutic agents to modulate cellular responses to hypoxia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Under normoxia, PHDs hydroxylate conserved proline residues within HIF-α subunits, increasing their affinity for the von Hippel–Lindau (pVHL) E3 ubiquitin ligase complex, which promotes polyubiquitination and 26S proteasomal degradation”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [44]
In the citing paper
“The subsequent discovery of a peptide from hypoxia-inducible factor 1 subunit-α (HIF1α) that bound the E3 ligase von Hippel–Lindau tumour suppressor (VHL)18,19 led to the design of cell-penetrating PROTACs that degraded a range of POIs.”
From PROTAC targeted protein degraders: the past is prologue (2022) · cites this paper as [18]
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648 · cited 1×
“Cycles of rebuilding and refinement were carried out using the programs”
MethodHershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Self-citationAQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR
Laskowski, R., Rullmann, J. A., MacArthur, M., Kaptein, R., & Thornton, J. (1996) · Journal of Biomolecular NMR · doi:10.1007/bf00228148 · Cited by 5,502
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Self-citationHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Research works printed but not linked: 1
- Hubbard, S. J. & Thornton, J. M. ‘NACCESS’, Computer Program Version 2.1.1 (Department of Biochemistry and Molecular Biology, Univ. Coll. London, London, 1996)
Cited by
Items 601–700 of 770
Construction and Development of a Cardiac Tissue-Specific and Hypoxia-Inducible Expression Vector
Ghaderi, S., Alidadiani, N., Rad, J. S., Heidari, H. R., Dilaver, N., Mansoori, B., Rhabarghazi, R., Parvizi, R., Khaze, V., & Baradaran, B. (2018) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2018.004 · Cited by 5
Adventures in Defining Roles of Oxygenases in the Regulation of Protein Biosynthesis
Walport, L. J., & Schofield, C. J. (2018) · The Chemical Record · doi:10.1002/tcr.201800056 · Cited by 6
Self-citationLoenarz, C. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201913263 · Cited by 5
Non-enzymatic protein targeting agents as a promising strategy for cancer treatment
Ambrose, M., Lee, J., Syed, A., Ahmed, Z., & Peng, G. (2025) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2025.1520734 · Cited by 4
Decoding the metabolic crosstalk between glycolysis and RNA viral pathogenesis
Bohara, V. S., & Kumar, S. (2025) · Virology · doi:10.1016/j.virol.2025.110766 · Cited by 6
Destabilization of HIF-1a by Diabetes, Oxidative Stress, Obesity and Other Related Disorders
Karavasilis, A., Καρκαλούσος, Π., Trapali, M., Fountzoula, C., & Karikas, G. A. (2023) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2023.132012 · Cited by 6
Application of A lpha F old models in evaluating ligandable cysteines across E 3 ligases
Koldenhof, P., Bemelmans, M. P., Ghosh, B. K., Damm‐Ganamet, K. L., van Vlijmen, H., & Pande, V. (2024) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26675 · Cited by 7
PROTACing the androgen receptor and other emerging therapeutics in prostate cancer
Zang, P. D., Seylani, A., Yu, E. Y., & Dorff, T. B. (2024) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2024.2379913 · Cited by 3
Dong, X., Su, X., Yu, J., Liu, J., Shi, X., Pan, Q., Yang, J., Chen, J., Li, L., & Cao, H. (2016) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2016.11.011 · Cited by 5
Belato, F. A., Mello, B., Coates, C. J., Halanych, K. M., Brown, F. D., Morandini, A. C., Leme, J. D. M., Trindade, R. I. F., & Costa-Paiva, E. M. (2023) · Geobiology · doi:10.1111/gbi.12577 · Cited by 5
“Prolyl hydroxylases (PHD) target defined proline residues (called the oxygen-dependent degradation domain, ODDD, on the HIF1a subunit (Figure 2a; Hon et al., 2002 ), which are recognized by the von Hippel– Lindau (VHL) protein and promote the ubiquitination mediated proteasomal degradation of HIF1a…”
BackgroundLakka, S. S., & Rao, J. (2008) · Springer eBooks · doi:10.1007/978-0-387-30375-8_1 · Cited by 4
Pan, J., Zhang, Y., Ran, T., Xu, A., Qiao, X., Yin, L., Zhou, W., Zhu, L., Zhao, J., Lu, T., et al. (2017) · Molecular Diversity · doi:10.1007/s11030-017-9750-y · Cited by 4
Yang, J., Wang, Q.-L., Feng, G., & Zeng, M. (2020) · Advanced Therapeutics · doi:10.1002/adtp.201900210 · Cited by 5
Cell Signaling and Transcription
Rehmani, I., Liu, F., & Liu, A. (2013) · Wiley eBooks · doi:10.1002/9781118355886.ch8 · Cited by 5
Targeting Protein–Protein Interactions Perspective
Chung, C., & Hann, M. M. (2020) · Wiley eBooks · doi:10.1002/9781118681121.ch20 · Cited by 6
HIF inhibition: Current strategies and clinical challenges
Więch-Walów, A., Bartoszewska, S., Barton, A., Czechowicz, P., Dudzik, J., Wielockx, B., Collawn, J. F., & Bartoszewski, R. (2026) · Redox biology · doi:10.1016/j.redox.2026.104220 · Cited by 3
“Under normoxia, PHDs hydroxylate conserved proline residues within HIF-α sub-units, increasing their affinity for the von Hippel – Lindau (pVHL) E3 ubiquitin ligase complex, which promotes polyubiquitination and 26S proteasomal degradation [32,44 – 47].”
Hypoxia Reduces Mouse Urine Output via HIF1α-Mediated Upregulation of Renal AQP1
Qiao, R., Cui, X., Hu, Y., Wei, H., Xu, H., Zhang, C., Du, C., Chang, J., Li, Y., Ming, W., et al. (2024) · Kidney Diseases · doi:10.1159/000542087 · Cited by 5
Shi, M., Zhou, X., Cai, Y., Li, P., Qin, D., Yan, X., Du, M., Li, S., & Xu, D. (2021) · Chinese Journal of Chemical Physics · doi:10.1063/1674-0068/cjcp2110198 · Cited by 3
Mathó, C., Fernández, M. C., Bonanata, J. N., Liu, X.-D., Martín, A., Vieites, A., Sansó, G., Barontini, M., Jonasch, E. W., Coitiño, E. L., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.854365 · Cited by 3
The EDN1 Missense Variant rs5370G > T Regulates Adaptation and Maladaptation under Hypobaric Hypoxia
Palmo, T., Abbasi, B. A., Chanana, N., Sharma, K., Faruq, M., Thinlas, T., Abdin, M. Z., & Pasha, Q. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191811174 · Cited by 4
Molecular Biology of Kidney Cancer
Kaelin, W. G. (2011) · Springer eBooks · doi:10.1007/978-3-642-21858-3_3 · Cited by 3
Hong, S., Yum, S., Ha, N., & Jung, Y. (2010) · Analytical Biochemistry · doi:10.1016/j.ab.2010.08.013 · Cited by 3
Regulation of Angiogenesis by Hypoxia-Inducible Factors
Hayakawa, H., & Shibasaki, F. (2013) · Springer eBooks · doi:10.1007/978-1-4614-5857-9_6 · Cited by 3
Molecular Biology of Iron in Nutritional Science.
Fujita, H., Nishitani, C., & NAKAJIMA, M. (2003) · Nippon Eiseigaku Zasshi (Japanese Journal of Hygiene) · doi:10.1265/jjh.58.248 · Cited by 4
REGULATION OF TRANSCRIPTION FACTOR ACTIVITY
Latchman, D. S. (2008) · Elsevier eBooks · doi:10.1016/b978-012373983-4.50016-x · Cited by 5
Early Events in Diabetic Retinopathy and Intervention Strategies
Tsin, A. T. C., & Grigsby, J. G. (2018) · InTech eBooks · doi:10.5772/intechopen.69906 · Cited by 5
The role of ascorbate in the regulation of HIF-1 in cancer cells
Kuiper, C. (2013) · Otago University Research Archive (University of Otago) · Cited by 2
Dual-targeting fluorous peptide proteolysis-targeting chimeras for cancer therapy
Rong, G., Li, Y., Zhu, F., Lu, Y., Sun, Z., Hong, J., & Cheng, Y. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114591 · Cited by 4
Design principles for optogenetic-based targeted protein degradation
Chen, Y., Wang, S., Xie, L., Zhang, L., Zhu, M., & Xu, Y. (2025) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2025.12.006 · Cited by 2
“Representative examples include the VHL-targeting VHLL heptapeptide (ALAPYIP) [45 – 47], C-terminal peptide collection (CtPC) [48], and PEST (regions rich in proline, glutamic acid, serine, and threonine) [49, 50].”
Molecular glues and PROTACs: unlocking targeted protein degradation in plant biology
Donderis-Fagoaga, C., Orea-Ordóñez, L., & Lozano‐Juste, J. (2026) · Journal of Experimental Botany · doi:10.1093/jxb/erag256 · Cited by 2
Analysis of von Hippel–Lindau Tumor Suppressor as a Mediator of Cellular Oxygen Sensing
Masson, N., & Ratcliffe, P. J. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)81021-8 · Cited by 2
Self-citationProteolysis Targeting Chimeric Molecules
Rodríguez-González, A., & Sakamoto, K. M. (2009) · Springer eBooks · doi:10.1007/978-0-387-69147-3_9 · Cited by 2
The Role of Angiogenesis in the Development of Psoriasis
Arruda, A. C. B. B., Siqueira, D. M., & Mercadante, L. M. (2017) · Springer eBooks · doi:10.1007/978-1-4471-7314-4_3 · Cited by 2
Wei, M., Chen, A., Zhang, J., & Ren, Y. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00503 · Cited by 2
KAÇMAZ, M., Trawally, M., & Güzel-Akdemir, Ö. (2024) · Journal of Research in Pharmacy · doi:10.29228/jrp.735 · Cited by 3
Moratalla, A. B. P., Carrión, B., Heras, K. V. G. D. L., Arias-Salazar, L., Yélamos-Sanz, B., Segura, T., & Serrano‐Heras, G. (2025) · Biomedicines · doi:10.3390/biomedicines13051234 · Cited by 3
Vollmer, L. L., Roberts, P., Eicher, S. L., Wołosowicz, M., Patel, P., Figura, J. R., Donahue, E. R., Berkowitz, J., Gavlock, D. C., Wipf, P., et al. (2025) · SLAS DISCOVERY · doi:10.1016/j.slasd.2025.100278 · Cited by 3
“HIF1 alpha is degraded by the ubiquitin system after proline hydroxylation [33-35].”
Therapeutic Strategies that Target the HIF System
Cook, K. M., & Schofield, C. J. (2008) · Springer eBooks · doi:10.1007/978-0-387-71518-6_32 · Cited by 2
Self-citationRajasekaran, R., Sudandiradoss, C., Doss, C. G. P., Singh, A., & Sethumadhavan, R. (2008) · Mammalian Genome · doi:10.1007/s00335-008-9143-8 · Cited by 3
Fukui, N., Kageyama, Y., Higashi, Y., Kihara, K., Kizaka‐Kondoh, S., Hiraoka, M., Shinojima, T., Suzuki, K., & Oya, M. (2013) · International Journal of Clinical Oncology · doi:10.1007/s10147-013-0568-z · Cited by 2
Loenarz, C., Chowdhury, R., Schofield, C. J., & Flashman, E. (2008) · Pure and Applied Chemistry · doi:10.1351/pac200880081837 · Cited by 3
Self-citationRegulation of endogenous erythropoietin production
Mole, D. R., & Ratcliffe, P. J. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8698-6_2 · Cited by 2
“permitting exquisite discrimination between the hydroxylated and nonhydroxylated forms of HIFα [89, 90].”
BackgroundSelf-citationGao, Y., Huang, Y., Tu, X.-A., Luo, D., Wang, D., Qiu, S., Peng, X., Li, W., Jan, R., Zhang, Y., et al. (2013) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20113162 · Cited by 2
VHL L169P Variant Does Not Alter Cellular Hypoxia Tension in Clear Cell Renal Cell Carcinoma
Hu, J., Smith, D., & Wu, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814075 · Cited by 3
“The N-terminal β-domain participates in substrate recognition and binding to HIFαs, while the α-domain interacts with elongin B and C [8,11,12].”
BackgroundWITHDRAWN: Utilizing comparative models in biomedical research
Little, A. G., Pamenter, M. E., Sitaraman, D., Templeman, N. M., Willmore, W. G., Hedrick, M. S., & Moyes, C. D. (2021) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2021.110938 · Cited by 3
RetractedThalidomide – From a Banned Drug to Molecular Glues, PROTACs, and New Concepts in Drug Discovery
Yamamoto, J., Handa, H., & Yamaguchi, Y. (2024) · Wiley eBooks · doi:10.1002/9781394182862.ch24 · Cited by 2
O’Brien, K. M., Rix, A. S., Jasmin, A., & Lavelle, E. (2024) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2024.101218 · Cited by 4
Advancing proteolysis targeting chimeras toward clinical drug developments
Tian, X., Huang, C., Yin, L., & Yu, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23932-8.00007-8 · Cited by 1
NRDN: A novel nuclear degradation tag for targeted protein regulation in Arabidopsis
Shen, L., Huang, H., Yan, D., Ye, Y., & Hu, J. (2025) · Plant Science · doi:10.1016/j.plantsci.2025.112529 · Cited by 1
Wei, S., & Liu, X. (2026) · High Altitude Medicine & Biology · doi:10.1177/15578682261428873 · Cited by 1
“1) (Greer et al., 2012; Hon et al., 2002; Pezzuto and Carico, 2018).”
Prolyl hydroxylase-dependent proteolysis enables the orthogonal hypoxia responses in plants
Shukla, V., Iacopino, S., Carbonare, L. D., Chiaro, A. D., He, Y., Tronca, M. N., Keeley, T. P., Papachristodoulou, A., Giuntoli, B., & Licausi, F. (2026) · Nature Communications · doi:10.1038/s41467-026-71366-3 · Cited by 2
Jiao, Y., Zhu, Z., Wang, R., He, B.-Y., Yao, H., Zhi-yong, Z., Shi, Y.-F., Wang, C., Cao, L., Liu, Y., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117749 · Cited by 1
Bee Venom Inhibits Angiogenesis by Decreasing HIF-1α Expression in HCT116 Cells
Shin, J.-M., Jeong, Y., Park, K., Choe, J., Han, S., Lee, K.-G., Yeo, J., Chung, I., & Chang, Y. (2012) · Journal of Life Science · doi:10.5352/jls.2012.22.1.41 · Cited by 1
THE VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN AND KIDNEY CANCER
Kaelin, W. G., & Ma, B. (2007) · Medicina-buenos Aires · Cited by 1
Evaluating Ligands for Ubiquitin Ligases Using Affinity Beads
Dobrodziej, J., Dong, H., Zimmermann, K., & Hickey, C. M. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1665-9_4 · Cited by 1
Biology of EPO and EPO-receptor
Lacombe, C., & Mayeux, P. (2008) · Springer eBooks · doi:10.1007/978-3-211-69459-6_2 · Cited by 1
Hypoxic Adaptation Facilitated by MIF
Mitchell, R. A. (2012) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814335362_0008 · Cited by 1
Structural and Biophysical Principles of Degrader Ternary Complexes
Zollman, D., & Ciulli, A. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781839160691-00014 · Cited by 3
Aulitzky, W. E., Beck, J., & Huber, C. H. (2004) · Springer eBooks · doi:10.1007/978-3-662-06670-6_50 · Cited by 1
Hypoxic Response and Associated Diseases
Flashman, E., Loenarz, C., & Schofield, C. J. (2008) · Wiley eBooks · doi:10.1002/9780470048672.wecb232 · Cited by 1
Self-citationProbing Protein Function with Small Molecules
Gough, J. D., & Crews, C. M. (2007) · Springer eBooks · doi:10.1007/978-3-540-37635-4_5 · Cited by 1
Controlled Oxygen Activation in Human Oxygen Sensor FIH
Saban, E. (2011) · Scholarworks (University of Massachusetts Amherst) · doi:10.7275/2395887 · Cited by 2
The regulation of hypoxia-responsive gene expression by hydroxyl radicals and intracellular calcium
Liu, Q. (2004) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-420
“Structures of HIF-1α-VHL complexes have elucidated a strict requirement for HIF-1α hydroxyproline in VHL binding (Hon et al., 2002; Min et al., 2002).”
BackgroundCloning and characterization of the rat HIF-1α prolyl-4-hydroxylase-1 gene
Cobb, R. R., McClary, J., Manzana, W., Finster, S., Larsen, B., Blasko, E., Pearson, J., Biancalana, S., Kauser, K. Z., Bringmann, P., et al. (2005) · Protein Expression and Purification · doi:10.1016/j.pep.2005.03.036 · Cited by 1
Oxygen-dependent Regulation of Transcription by the Hypoxia-inducible Factor-1
Ruas, J. L. (2005) · Figshare · Cited by 1
Fujimori, D. G. (2009) · Nature Chemical Biology · doi:10.1038/nchembio0409-202 · Cited by 1
SOCS Proteins and Cytokine Signalling: The many Faces of the SOCS Box
Piessevaux, J. (2008) · Ghent University Academic Bibliography (Ghent University) · Cited by 1
Regulation of Transcription Factor Activity
Latchman, D. S. (2004) · Elsevier eBooks · doi:10.1016/b978-012437178-1/50014-x · Cited by 2
Peng, Z., Liu, X., Zhan, Y., Liu, M., Zha, S., & Bao, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-2075041/v1 · Cited by 1
Shukla, V., Iacopino, S., Carbonare, L. D., He, Y., Chiaro, A. D., Papachristodoulou, A., Giuntoli, B., & Licausi, F. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.13.628401 · Cited by 1
Rescuing the Function of Missense-Mutated Tumor Suppressor VHL using Stabilizing Small MoleculesPreprint
Fouad, M. A., Parry, C. S., Miller, S. A., Malhotra, S., Doyle, G. A. R., Shimabenga, E., Nurilloeva, M., Bondarenko, E., Andrianov, G. V., Childers, W. E., et al. (2026) · eLife · doi:10.7554/elife.110305.2 · Cited by 1
Smith, G. (2015) · Enlighten: Theses (The University of Glasgow)
Hypoxia‐Inducible Factor 1 (HIF‐1) Mediated Adaptive Responses in the Solid Tumor
Golias, T., & Denko, N. C. (2010) · Wiley eBooks · doi:10.1002/9780470669891.ch12 · Cited by 1
The Role of the Ubiquitin–Proteasome Pathway in the Regulation of the Cellular Hypoxia Response
Nakayama, K., & Ronai, Z. A. (2007) · Wiley eBooks · doi:10.1002/9783527619320.ch6b
Miyata, T., & de Strihou, C. V. Y. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-857-7_32
“Hydroxylated HIF-a is recognized by Hippel–Lindau tumor suppressor protein (pVHL) [86, 87], which functions as an E3 ubiquitin ligase and is rapidly degraded by the proteasome [88, 89].”
BackgroundZheng, X. (2012) · Figshare
Regulated Extracellular Nucleotide Metabolism and Function at the Mucosa
MacManus, C. F., Eltzschig, H. K., & Colgan, S. P. (2010) · Springer eBooks · doi:10.1007/978-90-481-3435-9_8
“HIF-α in vitro [27, 30].”
Chi, S. (2008) · Genomics & Informatics · doi:10.5808/gi.2008.6.2.072
“The steady-state affinity constant of VCB (pVHL, elongins C and B) for the unmodified CODD peptide was estimated to be approximately 1000-fold less than the affinity for the hydroxylated CODD peptide ( Hon et al., 2002 ).”
BackgroundMethodInfluentialGossage, L. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1622-1_4 · Cited by 2
Targeting hypoxia-inducible factor-1 for therapy and prevention
Zhong, H. (2004) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.14.7.951
EFFECTS OF ERYTHROPOIETIN AND GLYCOGEN SYNTHASE KINASE 3 ON HYPOXIA INDUCIBLE FACTOR-1α
Hale, S. A. (2008) · ScholarWorks -A service of University of Vermont Libraries (University of Vermont)
Nelson, D. R. (2012) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 1
InflammationShifts in Immunity and
Kominsky, D. J., & Campbell, E. L. (2010)
Subcellular localization of hypoxia-inducible factors and HIF regulatory hydroxylases in rat liver.
Khan, Z. (2006) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Oxygen-Dependent Regulation of Erythropoiesis
Haase, V. H. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-857-7_23
Differential Regulation of c-FLIP Isoforms Through Post-translational Modifications
Kaunisto, A. (2009) · UTUPub (University of Turku)
Turnbull, D. W. (2008) · Scholars' Bank (University of Oregon)
Targeted Intracellular Protein Degradation as a Potential Therapeutic Strategy
Schneekloth, A. R., & Crews, C. M. (2010) · Royal Society of Chemistry eBooks · doi:10.1039/9781849732178-00064
Angiogenesis in Liver Cancer: General Aspects and Cellular Sources of Normal Angiogenesis
Zimmermann, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-26587-2_187-1
Regulation of Cellular Oxygen Sensing Pathways by VHL
Heir, P. (2015) · TSpace (University of Toronto)
A Novel Role for Tid1 in HIF2α Regulation
Burnett, D. (2010) · TSpace (University of Toronto)
Hétérérogénéité génétique de la polyglobulie
Dabbachi, M. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique)
THE ROLE OF N6-METHYLADENOSINE IN HYPOXIA AND CELLULAR TRANSFORMATION
Fry, N. J. (2017) · The Scholarship East Carolina University's Institutional Repository (East Carolina University)
Weaver, J. R., CASELLINI, C. M., Parson, H. K., & Vinik, A. I. (2018) · AACE Clinical Case Reports · doi:10.4158/accr-2017-0109
Transcriptomic profiling of VHL-dependent long noncoding RNAs in clear cell renal cell carcinoma
Samuel, J. N., & Marsden, P. A. (2018) · European Urology Supplements · doi:10.1016/s1569-9056(18)33803-x
Type 2B von Hippel-Lindau disease: molecular biology, tumor growth, and development
Lee, C. M. (2009) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/29tv-bb60
Di-Ras2 Promotes Renal Cell Carcinoma Formation by Activating the MAPK Pathway in the Absence of VHLPreprint
Rao, H., Li, X., Liu, M., Liu, J., Li, X., Xu, J., Li, L., & Gao, W. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/683821
Metadata
- Authors
- Hon, W.-C., Wilson, M. I., Harlos, K., Claridge, T. D. W., Schofield, C. J., Pugh, C. W., Maxwell, P. H., Ratcliffe, P. J., Stuart, D. I., & Jones, E. Y.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- Jones, E. Yvonne
- ORCID
- Venue
- Nature
- Published
- 2002-06
- Volume
- 417
- Issue
- 6892
- Pages
- 975-978
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2167786713
- Cited by
- 751
- References
- 31
- Citations by year
- 2026: 22 · 2025: 35 · 2024: 46 · 2023: 43 · 2022: 37 · 2021: 35 · 2020: 43 · 2019: 19 · 2018: 24 · 2017: 23 · 2016: 28 · 2015: 24 · 2014: 20 · 2013: 23 · 2012: 26
- FWCI
- 17.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- HIF-1α, von Hippel-Lindau protein, E3 ubiquitin ligase, hypoxia, oxygen sensing, protein-protein binding, crystal structure, hydrogen bonding, ubiquitination, proteasomal degradation, transcriptional regulation
- MeSH terms
- Elongin, Amino Acid Sequence, Hypoxia, Binding Sites, Humans, Hydrogen Bonding, Hydroxylation, Hydroxyproline, Kinetics, Ligases, Models, Molecular, Molecular Sequence Data, Protein Binding, Protein Conformation, Structure-Activity Relationship, Substrate Specificity, Transcription Factors, Sequence Alignment, Crystallography, X-Ray, Surface Plasmon Resonance, Amino Acid Motifs, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.